Literature DB >> 5496921

Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment.

B Scatton, A Cheramy, M J Besson, J Glowinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5496921     DOI： 10.1016/0014-2999(70)90194-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  27 in total

1.  Acute and subacute effects of neuroleptics dopamine synthesis and release in the rat striatum.

Authors:  B Scatton; C Garret; L Julou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Possible new mechanism for the antiparkinsonian effect of amantadine.

Authors:  V L Bennett; A V Juorio; X M Li
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

Review 3.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

Review 4.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

5.  Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.

Authors:  J D Parkes; R C Baxter; C D Marsden; J E Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

6.  In vitro studies on the possible effects of 1-aminoadamantanes on the serotonergic system in M. Parkinson.

Authors:  W Wesemann; G Dette-Wildenhahn; H Fellehner
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

7.  Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.

Authors:  J Kornhuber; M Weller
Journal:  J Neural Transm Gen Sect       Date:  1993

8.  Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1971-07-10       Impact factor: 8.262

9.  Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.

Authors:  G M Pacifici; M Nardini; P Ferrari; R Latini; C Fieschi; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

10.  Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants.

Authors:  M K Menon; C A Vivonia; V G Haddox
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.